Who
Gines Diego Miralles
President & Head of R&D
Company insider
Files Form 4 as: President & Head of R&D, Artiva Biotherapeutics; Director, Contineum Therapeutics; Director, NeuBase Therapeutics.
In numbers
- Trades disclosed
- 15
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 2
- First trade
- 12 Jul 2019
- Last trade
- 9 Sep 2026
- Last filed
- 11 Sep 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Sep 2026filed 11 Sep 2026 | ARTV Artiva BiotherapeuticsBiotechnology | SEC FORM 4 Code A | —45,000 at $0.00 | filing |
| 9 Sep 2026filed 11 Sep 2026 | ARTV Artiva Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —135,000 at $0.00 | filing |
| 9 Sep 2026filed 11 Sep 2026 | ARTV Artiva Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —135,000 at $0.00 | filing |
| 9 Sep 2026filed 11 Sep 2026 | ARTV Artiva BiotherapeuticsBiotechnology | SEC FORM 4 Code A | —45,000 at $0.00 | filing |
| 26 Jun 2026filed 26 Jun 2026 | CTNM Contineum Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —19,000 at $0.00 | filing |
| 26 Jun 2026filed 26 Jun 2026 | CTNM Contineum Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —19,000 at $0.00 | filing |
| 18 May 2026filed 19 May 2026 | ARTV Artiva BiotherapeuticsBiotechnology | SEC FORM 4 Code A | —77,500 at $0.00 | filing |
| 18 May 2026filed 19 May 2026 | ARTV Artiva Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —232,500 at $0.00 | filing |
| 18 May 2026filed 19 May 2026 | ARTV Artiva Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —232,500 at $0.00 | filing |
| 18 May 2026filed 19 May 2026 | ARTV Artiva BiotherapeuticsBiotechnology | SEC FORM 4 Code A | —77,500 at $0.00 | filing |
| 26 Jun 2025filed 26 Jun 2025 | CTNM Contineum Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —14,750 at $0.00 | filing |
| 24 Jun 2025filed 26 Jun 2025 | ARTV Artiva Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —13,750 at $0.00 | filing |
| 14 Mar 2025filed 17 Mar 2025 | CTNM Contineum Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —29,500 at $0.00 | filing |
| 9 Sep 2020filed 11 Sep 2020 | NeuBase Therapeuticsoption or derivative | SEC FORM 4 Code A | —14,634 at $0.00 | filing |
| 12 Jul 2019filed 16 Jul 2019 | NeuBase Therapeuticsoption or derivative | SEC FORM 4 Code A | —227,330 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.